Blog

  1. January 12, 2024

    Cause (and cure?) for morning sickness

    Morning sickness is all about the hormones. That part isn’t surprising, but what’s newsworthy is that USC researchers say they’ve discovered exactly which hormone it is — and (potentially) what can be done about it.

    The hormone is called GDF15, and it’s produced by the fetus; it surges in the first trimester.

    “[T]he baby growing in the womb is producing a hormone at levels the mother is not used to. The more sensitive she is to this hormone, the sicker she will become. Knowing this gives us a clue as to how we might prevent this from happening.”

    Some women are especially sensitive to GDF15 and can have morning sickness that requires hospitalization. (Looking at you, Catherine, Princess of Wales.) Other woman have a genetic blood disorder that gives them chronically high levels of GDF15 so they

    Read More
  2. January 09, 2024

    Compounded Liothyronine (T3): What you need to know

    Clinical info on liothyronine

    By Zoom Heaton, RPh., CDCES, ABAAHP, FAAMFM
    Clinical Liaison – Women’s Health
    Revelation Pharma

    Liothyronine is a synthetic form of triiodothyronine (T3), one of the two primary thyroid hormones produced by the thyroid gland. It is commonly used in the treatment of hypothyroidism, a condition characterized by insufficient production of thyroid hormones.

    Clinical studies have demonstrated the effectiveness of liothyronine in improving symptoms and normalizing thyroid hormone levels in patients with hypothyroidism. One study, published in The Journal of Clinical Endocrinology & Metabolism, investigated the effects of liothyronine and levothyroxine (T4) combination therapy versus levothyroxine monotherapy in patients with hypothyroidism. The study found that combination therapy resulted in greater improvements

    Read More
  3. January 05, 2024

    Two — no, THREE! — Revelation-family techs score scholarships

    A huge congrats to a pair trio of pharmacy compounding champs: Jessica Myers and Kaleasha Piranti of Stanley Specialty Pharmacy in Charlotte, N.C. and Dana Epps of Eagle Pharmacy of Hoover, Ala.

    Together they’ve received grants worth almost $1,500 from the Alliance of Pharmacy Compounding’s Pharmacy Compounding Foundation to attend a 15-hour course, “The Ethical, Legal, and Regulatory Foundations of Pharmacy Compounding” offered by Virginia Commonwealth University.

    The course will give them some top-notch training to hone in their compounding skills, and it’ll teach them the ins and outs of not just the legal issues, but how to keep their ethical standards at their peak.

    Nice job, Jessica and Kaleasha! (Psst: You, too, can take the course — click here for info.)

    Read More
  4. January 04, 2024

    High-five for one staffer in 20 Ways

    Shout-out to our own Emily Durham — she’s got an article in the latest edition of Rx Insider’s 20 Ways magazine: (almost) everything you need to know about the new USP Chapter <795> updates. Click here to check it out.

    For non-pharmacists, USP chapters are one of the important ways of ensuring compounded medications are safe, and that compounding pharmacists are always practicing at the tops of their games. Chapters like <795> cover best practices for everything from updated safety protocols to education requirements — and a lot more.

    We’re proud to have Emily’s article in a prominent pharmacy magazine like 20 Ways — just more proof that the Revelation Pharma family has the best and brightest of compounding pharmacy!

    Read More
Page